Ann: Non-Renounceable Entitlement Offer - Results, page-10

Same here, the SP fall is painful.

Polynovo has around $40mil in revenue, not sure we can compare them other than the fact that they are in the same industry.

But look at it this way, they (Osteopore) own the distribution chain now, which provided almost 50 % of the revenues last FY. With better margins and new partnerships I would be really really surprised to see lower revenue. Regardless of the current SP, I am forecasting better revenues.

They need to monitor the cash burn very very closely from here, but a push for aggressive sales is coupled with a higher burn rate usually - so it's a tricky spot to be in with the amount of cash they have.

We really need a HNW Investor to invest - I might get in touch with the management to see what they plan to do. They operate out of SG surely they can convince one of the many HNW Investors to fund them ha ha